When was Source Molecular founded?

Source Molecular was founded in 2002 and raised its 1st funding round 15 years after it was founded.

Where is Source Molecular located?

Source Molecular is headquartered in Miami, United States.

Who is the current CEO of Source Molecular?

Mauricio Larenas of Source Molecular.

How many employees does Source Molecular have?

As of Apr 30, 2026, the latest employee count at Source Molecular is 3.

Is Source Molecular a funded company?

Source Molecular is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 11, 2017.

When was the latest funding round of Source Molecular?

Source Molecular's latest funding was a $***** Series A round on Jul 11, 2017, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $632M in funding in 2026 to date.

Where does Source Molecular rank among its competitors?

Source Molecular ranks 16th amongst 148 active competitors, of which 7 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was AFYREN, which secured $3.51M in Apr, 2026.

Who are the top competitors of Source Molecular?

Source Molecular's top competitors include AFYREN, Rooter and Spore Biotechnologies. Among them, AFYREN secured the most recent funding round in April, 2026.

Source Molecular - 2026 Company Profile, Team, Funding & Competitors

Source Molecular is an acquired company based in Miami (United States), founded in 2002. It operates as a Provider of technology for microbial source tracking. Source Molecular has raised $1.62M in funding from New World Angels. The company has 148 active competitors, including 7 funded and 36 that have exited. Its top competitors include companies like AFYREN, Rooter and Spore Biotechnologies.

Company Details

Website: sourcemolecular.com
Email ID: *****@sourcemolecular.com
Phone Number: +1 **********

Key Metrics

Founded Year

2002

Location

Miami, United States

Stage

Acquired

Total Funding

$1.62M in 1 round

Latest Funding Round

Series A, Jul 11, 2017, $*****

Investors

New World Angels & 2 more

Ranked

16^th among 148 active competitors

Employee Count

3 as on Apr 30, 2026

Similar Companies

AFYREN & 61 more

Exit Details

Acquired by LuminUltra (Nov 30, 2020)

View Source Molecular's full profile

Source Molecular is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SOURCE MOLECULAR CORPORATION CIN: 51-0423763 , United States, Active	Dec 31, 2001	-	-	-

Source Molecular got acquired by LuminUltra on Nov 30, 2020.

Click here to take a look at Source Molecular's acquisition in detail

Source Molecular has raised a total funding of $1.62M over 1 round. Its latest funding round was a Series A round on Jul 11, 2017 for $*****. 1 investor participated in its latest round. Source Molecular has 3 institutional investors.

Here is the list of recent funding rounds of Source Molecular:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 11, 2017	5024869	Series A	1027536	2045324	2253123	2737621

Access funding benchmarks and valuations. Sign up today!

View details of Source Molecular's funding rounds and investors

Source Molecular's employee count trend

Source Molecular has 3 employees as of Apr 26. Here is Source Molecular's employee count trend over the years:

Employee count trend for Source Molecular

Uncover Source Molecular's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Source Molecular include AFYREN, Rooter and Spore Biotechnologies. Here is the list of Top 10 competitors of Source Molecular, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AFYREN 2012, Paris (France), Public	Provider of analytical services for microbiology, chemistry and bioprocesses industries	$132M	Kemin, Sofinnova Partners & 12 others	62/100
2nd	Rooter 1935, Cincinnati (United States), Acquired	Provider of plumbing and drainage cleaning services	-	-	58/100
3rd	Spore Biotechnologies 2022, Paris (France), Series A	Developer of microbial detection technology for life science industries	$35M	LocalGlobe, Singular & 13 others	56/100
4th	Hach 1947, Loveland (United States), Acquired	Manufacturer of sensors and controllers for water quality testing applications	-	Identity Partners	48/100
5th	GBA Group 1975, Hamburg (Germany), Acquired	Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry	-	Adiuva Capital	44/100
6th	Biopsin 2018, Singapore (Singapore), Seed	Developer of real-time microbial detection system	$175K	Entrepreneur First, HAX & 2 others	41/100
7th	Tepnel Pharma Services 2013, Wythenshawe (United Kingdom), Acquired	Provider of analytical and quality testing services for drug development and diagnostics	-	-	41/100
8th	NCIMB 1982, United Kingdom, Early Stage	Provider of biorepository, microbial culture collection and microbiology services	$2.27M	The Scottish National Investment Bank, Maven Capital Partners ... & 2 others	41/100
9th	Outpost Bio 2025, Boston (United States), Seed	Developer of artificial intelligence to analyze microbial ecosystems for medicine	$3.5M	Seedcamp, Merantix Capital & 2 others	40/100
10th	Maine Water 1880, Hartford (United States), Acquired	Provider of water quality services	-	-	40/100
16th	Source Molecular 2002, Miami (United States), Acquired	Provider of technology for microbial source tracking	$1.62M	Westlake Ventures, Miramar Group & 1 others	35/100